To verify the expression of TILRR and the infiltration of immune cells, the 50 highest TILRR-expressing and 50 lowest TILRR-expressing tumor tissue samples were selected (TCGA database) to analyze the expression of marker genes for CD8+, CD4+ and T cells (general). The gene discussed is CD4; the disease is neoplasm.